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Modulation of HSP25 and TNF- during the early stages of functional
overload of a rat slow and fast muscle
Kimberly A. Huey,1 Gary E. McCall,2 Hui Zhong,3 and Roland R. Roy3
1Department of Kinesiology, University of Illinois, Urbana, Illinois; 2Department of Exercise Science, University of Puget
Sound, Tacoma, Washington; and 3Brain Research Institute, University of California, Los Angeles, California
Submitted 5 January 2007; accepted in final form 16 March 2007
Huey KA, McCall GE, Zhong H, Roy RR. Modulation of HSP25
and TNF- during the early stages of functional overload of a rat slow
and fast muscle. J Appl Physiol 102: 2307–2314, 2007. First published
March 22, 2007; doi:10.1152/japplphysiol.00021.2007.—Early events in
response to abrupt increases in activation and loading with muscle
functional overload (FO) are associated with increased damage and
inflammation. Heat shock protein 25 (HSP25) may protect against
these stressors, and its expression can be regulated by muscle loading
and activation. The purpose of this study was to investigate the
responses of HSP25, phosphorylated HSP25 (pHSP25), and tumor
necrosis factor- (TNF-) during FO of the slow soleus and fast
plantaris. We compared the HSP25 mRNA, HSP25 protein, pHSP25,
and TNF- responses in the soleus and plantaris after 0.5, 1, 2, 3, and
7 days of FO. HSP25 and pHSP25 were quantified in soluble and
insoluble fractions. HSP25 mRNA increased immediately in both
muscles and decreased with continued FO. However, HSP25 mRNA
levels were consistently higher in the muscles of FO than control rats.
In the soluble fraction, HSP25 increased in the plantaris after 2–7 days
of FO with the greatest response at 3 and 7 days. The pHSP25
response to FO was greater in the plantaris than soleus at all points in
the soluble fraction and at 0.5 days in the insoluble fraction. TNF-
levels in the plantaris, but not soleus, were higher than control at 0.5–2
days of FO. This may have contributed to the greater FO response in
pHSP25 in the plantaris than soleus as TNF- increased pHSP25 in
C2C12 myotubes. These results suggest that the initial responses of
pHSP25 and TNF- to mechanical stress and inflammation associated
with FO are greater in a fast than slow extensor muscle.
heat shock protein 25; phosphorylation; tumor necrosis factor-alpha;
skeletal muscle
HEAT SHOCK PROTEINS (HSP) were initially discovered and
named based on their rapid induction in response to elevated
temperatures. However, ongoing research has clearly demon-
strated that HSPs respond to a wide variety of physical and
chemical stresses (6, 56), and growing evidence supports their
important role in maintaining skeletal muscle structure and
function (35). Whereas one of the larger HSPs, HSP70, has
been studied more extensively in skeletal muscle, limited data
exist regarding the role of small HSPs, such as HSP25 (ho-
mologous to human HSP27) in skeletal muscle function and
integrity. However, a role for HSP25 in skeletal muscle is
underscored by evidence suggesting its ability to protect mus-
cle cells from stressors such as atrophy associated with de-
creased use (33, 48), oxidative damage (10), and muscle
mechanical damage (21, 22, 28). Furthermore, reduced HSP25
expression has been implicated in muscle diseases such as
muscular dystrophy (46). Although the functions of HSP25 in
chaperoning unfolded proteins, stabilizing the cytoskeleton,
conferring resistance to oxidative stress and inflammation, and
inhibiting apoptosis (6) are documented in other cell types such
as fibroblasts and smooth muscle cells, its specific functions in
skeletal muscle are less clear. Importantly, factors that
regulate the phosphorylation state of HSP25 (pHSP25) in
skeletal muscle are poorly understood. Recent studies are
only beginning to isolate the factors that impact HSP25
phosphorylation in muscle (16, 20), and more studies are
necessary to provide the groundwork for future studies
elucidating how phosphorylation impacts the functional
properties of HSP25 in muscle.
The abrupt and chronic increases in muscle loading and
activation induced by synergist removal (2, 3, 12, 25) provide
a relevant model to investigate initial factors that contribute to
changes in the expression and phosphorylation of HSP25.
Previously, our laboratory reported increases in HSP25 and
pHSP25 after 3 or 7 days of functional overload (FO) (15);
however, responses critical for the remodeling of the muscle
likely begin soon after the onset of overload. For example,
early changes include elevated expression of proinflammatory
cytokines such as tumor necrosis factor- (TNF-) (53) and
the rapid phosphorylation of the mitogen-activated protein
(MAP) kinases within 24 h of muscle overload (4). MAP
kinase activation is a good indicator of immediate increases in
muscle loading and activation (29), changes that likely con-
tribute to muscle damage (5, 50) in the overloaded muscles.
Because the immediate translocation of HSP25 and/or pHSP25
to the insoluble fraction has been shown to stabilize cytoskel-
etal elements and help maintain muscle structure after damag-
ing contractions (22), it is likely that alterations in HSP25 and
pHSP25 are among the earliest responses to FO.
During the initial stages of FO, increases in muscle weight
are generally indicative of inflammation (2) rather than the
increases in muscle protein levels (1). The expression of
TNF- is significantly elevated in overloaded muscle (53), and
HSP25 has been shown to protect cells from TNF--induced
damage (30, 40, 44). Importantly, both TNF- and muscle
damage are associated with increased HSP25 phosphorylation.
TNF--dependent phosphorylation of HSP25 has been shown
in fibroblasts via activation of p38 MAP kinase and MAP
kinase-activated protein kinase 2 (9, 39, 44). Furthermore,
following damaging muscle contractions, increases in HSP25
in the insoluble fraction, where it may stabilize or repair
cytoskeletal elements, is associated with increased HSP25
phosphorylation (22). Taken together with data in nonmuscle
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cells (14, 18, 23, 24), the ability of HSP25 to stabilize cytoskel-
etal elements is likely phosphorylation dependent. Thus muscle
damage induced by the abrupt increases in muscle loading
associated with FO (5, 50) may be attenuated by increases in
pHSP25.
To date, no studies have investigated how rapidly HSP25
expression is induced in response to the initial stress of FO and
the associated inflammatory response. Furthermore, the time
course of changes in the phosphorylation state of HSP25 under
these conditions and whether TNF- is involved in this re-
sponse are unknown. Moreover, a comparison of the adapta-
tions in HSP25 expression and phosphorylation between a
predominately slow and a predominantly fast muscle will
provide unique insight into muscle-specific factors that regu-
late the HSP25 response. Therefore, the primary purpose of the
present study was to test the hypothesis that rapid increases in
HSP25 phosphorylation and/or HSP25 expression occur in
response to overload in a muscle-specific fashion. We com-
pared HSP25 mRNA, HSP25 protein, and pHSP25 in the rat
soleus and plantaris muscles, plantar flexors with different
myosin heavy chain (MHC) profiles and mechanical proper-
ties, after 0.5, 1, 2, 3, and 7 days of FO. Because the soleus is
a predominantly slow, highly oxidative, and tonically active
muscle, whereas the plantaris is a predominantly fast, more
glycolytic, and more phasically active muscle, we hypothe-
sized that the HSP25 response (fold change from control
baseline values within each muscle) in the soleus would be
lower than the plantaris due to the greater relative changes in
loading and activation induced by FO in the fast than the slow
muscle. HSP25 and pHSP25 levels were quantified in both the
soluble and insoluble fractions to test the hypothesis that the
increased activation and loading imposed on the muscles (and
probable muscle damage) increases HSP25 and/or pHSP25
levels in the insoluble fraction where it may help stabilize
cytoskeletal elements (22). We also investigated changes in
TNF- as a possible mechanism contributing to increases in
HSP25 phosphorylation in skeletal muscle both in vivo, in the
overloaded soleus and plantaris, and in vitro, in C2C12 myo-
tubes. We hypothesized that TNF- increases HSP25 phos-
phorylation in isolated skeletal muscle cells and that muscle-
specific differences in TNF- levels are associated with dif-
ferences in the pHSP25 responses.
MATERIALS AND METHODS
Experimental design. This study was approved by the Animal Use
Committee at the University of California, Los Angeles, and it
followed the American Physiological Society animal care guidelines.
Adult, female Sprague-Dawley rats (initial mean body weight of
228  1 g) were assigned randomly to a day 0 or day 7 control group
(Con-0d and Con-7d, respectively) and one of the following FO
groups: 1) 0.5-day FO (FO-0.5d), 2) 1-day FO (FO-1d); 3) 2-day FO
(FO-2d), 4) 3-day FO (FO-3d), or 5) 7-day FO (FO-7d) (n  5/group
for each time point). The overload period was initiated when the
animals began moving around the cages. There were no significant
differences in initial body weight among the groups. All surgical
procedures were performed under aseptic conditions with the rats
deeply anesthetized (100 mg ketamine and 5 mg acepromazine/kg
body wt). Overload of the plantaris and soleus muscles was performed
bilaterally via removal of their major synergistic muscle, the gastroc-
nemius, as described in detail previously (3). Based on our previous
(15) findings, sham operations were not performed on the Con groups.
We compared HSP25 expression and phosphorylation between con-
trol and 1-day (n  3) or 3-day (n  4) sham-operated animals and
found no differences in either the soleus or plantaris values. Compar-
isons between control and 3-day sham-operated soleus and plantaris
were reported previously (15). Values in the sham-operated soleus
were normalized to control (1.0) and were 0.94  0.02 and 0.98 
0.02 for HSP25 and pHSP25, respectively, after 1 day. Normalized
values in the sham-operated plantaris were 0.99  0.02 and 1.05 
0.04 for HSP25 and pHSP25, respectively, after 1 day. Furthermore,
there were no significant changes in HSP25 mRNA in either the
plantaris or soleus after 1 or 3 days of sham surgery. All of these data
indicate that the results reported in the present study are attributable to
the muscle overload and not the surgical procedures. At the predeter-
mined time points, the rats were euthanized with an overdose of
pentobarbital sodium (100 mg/kg body wt), and the plantaris and
soleus muscles were removed bilaterally, quickly trimmed of excess
fat and connective tissue, wet weighed, frozen in liquid nitrogen, and
stored at 80°C until subsequent analysis. The muscles from a single
leg of each animal were analyzed for both mRNA and protein. The
midbelly of each muscle was used for analysis.
mRNA analyses. Muscle samples (50–60 mg) were homogenized
in 1 ml of TRI Reagent (Molecular Research Center, Cincinnati, OH),
and RNA was extracted according to the manufacturer’s protocol.
RNA concentration was determined with a spectrophotometer and
stored at 80°C for subsequent RT-PCR.
Quantitative real-time RT-PCR was used to determine the expres-
sion of HSP25 mRNA relative to -actin. One microgram of total
RNA from each muscle sample was reverse transcribed using the
Stratascript first-strand synthesis system (Stratagene, La Jolla, CA)
according to the manufacturer’s protocol.
For gene expression analysis, 1 l of the RT reaction was added to
a reaction mix containing 1 Full-velocity SYBRgreen (Stratagene)
and 150 nM of the HSP25 or -actin primer pairs. Amplification and
quantitation of mRNA were performed on a Stratagene Mx3000P with
the following parameters: a denaturing step at 95°C for 5 min,
followed by 10 s at 95°C and 30 s at 60°C for 40 cycles. The primer
sequences were as follows for HSP25: forward 5-TGGCTACATCTCTCG-
GTGCT-3, reverse 5-ATGGTGATCTCCGCTGATTG-3 and -actin:
forward 5-TGGAGAAGATTTGGCACCA-3, reverse 5-CCAGAG-
GCATACAGGGACAA-3 (Operon, Huntsville, AL) and generated
fragments of 150 and 193 bp, respectively. All primer pairs produced
a dilution curve of cDNA with a slope of 100  10% “efficiency”
where 100%  	3CT/log cDNA input (CT is the threshold PCR cycle
at which fluorescence is detected above baseline). Fluorescence mea-
surements were taken at the end of each cycle (product extension
period). After amplification, a melting curve analysis was performed
to verify amplification product specificity. Briefly, amplification prod-
ucts were denatured at 95°C for 1 min, and then they were quickly
cooled to 55°C for 30 s. This was followed by a ramp up to a final
temperature of 95°C while continuously measuring fluorescence. The
derivative of the melting curve fluorescence was plotted vs. temper-
ature, thus yielding melting peaks indicative of products generated
during amplification. The lack of primer-dimer complexes and the
presence of an appropriate single peak in the resultant melting curve
were indicators of correct amplification products. In initial experi-
ments, PCR products were separated on 2% agarose gels, stained with
ethidium bromide, and photographed under UV light to validate that
the PCR products were the appropriate size and that no artifact bands
were present. Additional controls included the elimination of
Stratascript RT enzyme during cDNA synthesis (demonstrating the
absence of DNA contamination) and the elimination of cDNA during
PCR to demonstrate no contaminants in the PCR Master Mix. All
PCR reactions were performed in duplicate for each RT product. The
relative expression level of HSP25 was normalized by subtracting the
corresponding -actin threshold cycle (CT) values and using the
		CT comparative method (47).
Protein analyses. Plantaris or soleus (n  5/time point) muscles
from Con-0d, Con-7d, FO-0.5d, FO-1d, FO-2d, FO-3d or FO-7d
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animals were homogenized in 10 volumes of an ice-cold buffer
containing 50 mM TrisHCl (pH 7.8), 2 mM potassium phosphate, 2
mM EDTA, 2 mM EGTA, 10% glycerol, 1% Triton X-100, 1 mM
dithiothreitol, 3 mM benzamidine, 1 mM sodium orthovanadate, 10
mM leupeptin, 5 mg/ml aprotinin, and 1 mM 4-[(2-aminoethyl)
benzenesulfonyl fluoride] using a motor-driven glass pestle. The
homogenate was immediately centrifuged at 12,000 g for 20 min at
4°C. The supernatant was removed as the detergent-soluble fraction.
The detergent-insoluble fraction was obtained by resuspending the
pellet in 10 mM Tris (pH 6.8), 2% SDS, and 2.5% -mercaptoethanol
and homogenizing with a motor-driven glass pestle. The remaining
insoluble fraction was removed by centrifugation. Protein concentra-
tions were determined using the Bio-Rad Protein Assay with bovine
serum albumin (BSA) used for the standard curve. The samples were
saved immediately in aliquots at 80°C for subsequent use in immu-
noblotting.
Western blot analysis was used to determine HSP25 and pHSP25
protein levels in Con-0d, Con-7d, FO-0.5d, FO-1d, FO-2d, FO-3d, or
FO-7d soleus and plantaris muscles. Thirty micrograms of detergent-
soluble or -insoluble proteins were boiled (5 min at 95°C) and
separated by one-dimensional SDS-PAGE (12.5%) and transferred to
nitrocellulose membranes (pore size 45 m). After protein transfer,
the membranes were blocked for 1 h in Tris-buffered saline (TBS)-5%
milk. Following blocking, the membranes were incubated overnight at
4°C with an anti-HSP25 (1:5,000) or anti pHSP25 (Ser82) (1:1,000)
antibody in TBS-2.5% BSA. The HSP antibodies were purchased
from Stressgen (Ann Arbor, MI). Blots were washed three times in
TBS-0.1% Tween and incubated with anti-rabbit secondary antibodies
(Amersham Biosciences, Piscataway, NJ) at 1:5,000 for 1 h at room
temperature. Blots then were washed in TBS-0.1% Tween, and the
bound antibodies were detected with enhanced chemiluminescence
(Amersham Biosciences). Blots were first probed for pHSP25 and
subsequently stripped and reprobed for HSP25 to normalize pHSP25
to total HSP25.
Quantification of the bands was performed using ImageQuant
Analysis software. All the necessary controls for Western blots were
performed to ensure antibody specificity. To ensure uniformity, only
bands within the same blot were used to compare the relative amounts
of each protein among groups. The intensity of phosphorylated bands
for HSP25 was first normalized to the intensity of the corresponding
nonphosphorylated bands, and the ratio was normalized to control
values.
TNF- analyses. Soleus and plantaris muscles were homogenized
in Tris buffer described above and the levels of TNF- measured by
ELISA (Endogen, IL) with detection limits of
1 pg/mg. These lower
detection limits are sufficient to measure cytokine concentrations in
muscle homogenates. Muscle TNF- concentrations are expressed as
picograms per milligram protein.
Cell culture and TNF- experiments. Mouse C2C12 myoblasts were
maintained in DMEM supplemented with 10% fetal calf serum at
37°C and 5% CO2. Differentiation and fusion were induced by
switching cultures to DMEM supplemented with 2% horse serum
(DM). Within 3 days in DM, cultures consistently fused into myo-
tubes and all experiments were conducted after 4 days in DM. Initial
dose-response experiments were performed with four TNF- doses
(0.1, 1, 10, or 100 ng/ml; Chemicon, CA), and the increase in pHSP25
was quantified. The optimal dose based on the pHSP25 response
was determined to be 10 ng/ml, and this dose was used in all
subsequent experiments. For experiments with the MAP kinase
inhibitor, SB-203580, cells were pretreated with 1 or 10 g 30 min
before the addition of TNF-. Experiments were performed by adding
10 ng/ml murine recombinant TNF- for 15, 30, 60, or 120 min. Cell
lysates were harvested in 100 l of the Tris buffer and subjected to
Western blot analysis as described above.
Statistical analyses. All data are presented as means SE. Because
there were no differences in HSP25 mRNA, HSP25, or pHSP25
between Con-0d and Con-7d groups, these data were pooled, and a
single Con value was calculated and compared with all other time
points. Differences in muscle weights in the soleus or plantaris in
Con-0d, Con-7d and after 0.5, 1, 2, 3, or 7 days of FO were
determined using a one-way ANOVA. Two-way ANOVAs were used
to assess main effects of days of FO (0.5–7 days), muscle (soleus vs.
plantaris), or interactions between days of FO and muscle on HSP25
mRNA, HSP25 protein, pHSP25, or TNF- in the soleus or
plantaris muscles after 0 h (Con), 0.5, 1, 2, 3, or 7 days of FO.
Differences in pHSP25 and HSP25 protein levels in C2C12 cells
after 0-, 30-, 60-, 90- or 120-min exposure to TNF- were
determined using a one-way ANOVA. If significant differences
were found, the Bonferroni post hoc test was used to determine the
source of the difference. Significant differences between initial and
final body weights were determined with paired two-tailed t-tests.
All analyses were performed with Graphpad Prism 4.0 with the
significance level set at P 
 0.05.
RESULTS
Changes in body and muscle weights. Initial mean body
weights for the Con-0d, Con-7d, FO-0.5d, FO-1d, FO-2d,
FO-3d, and FO-7d groups were 223  2, 229  6, 234  2,
231  3, 224  4, 220  1, and 233  4 g, respectively. The
terminal mean body weights varied among the groups as a
result of significant increases from initial weights in the
Con-7d and FO-7d groups compared with Con-0d (Table 1).
Muscle weights were not increased above control values until
7 days of FO for either the plantaris or soleus. Mean absolute
Table 1. Terminal body weight, absolute muscle weight, and relative muscle weight (to body weight) for control, 7-day
control, 0.5-day functional overload, 1-day functional overload, 2-day functional overload, 3-day functional
overload, and 7-day functional overload groups
Muscle Wet Weight, mg Relative Muscle Wet Weight, mg/g
Body Weight, g Soleus Plantaris Soleus Plantaris
Con-0d 2232 1133 2544 0.510.02 1.140.02
Con-7d 2517§† 1082 2456 0.470.01 1.000.01
FO-0.5d 2392 1163 2624 0.490.01 1.120.01
FO-1d 2321* 1262 2632 0.550.01 1.140.01
FO-2d 2253* 1263 2515 0.560.01 1.130.02
FO-3d 2263* 1277 2658 0.580.03 1.200.03
FO-7d 2462§† 1507‡ 3087‡ 0.640.03† 1.320.04‡
Values are means SE; n 5/group. Con-0d, control; Con-7d, 7-day control; FO-0.5d, 0.5-day functional overload; FO-1d, 1-day functional overload; FO-2d,
2-day functional overload; FO-3d, 3-day functional overload; FO-7d, 7-day functional overload. *Significantly different from Con-7d and FO-7d, P 
 0.05.
†Significantly different from Con-0d, P 
 0.05. ‡Significantly greater than all other time points, P 
 0.05. §Significantly greater than Con-0d, Con-7d and
FO-0.5d, (P 
 0.05).
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weights of the plantaris and soleus were 121 and 133% of
Con-7d values, respectively, after 7 days of FO. Mean plantaris
and soleus weights expressed relative to body weight were 115
and 121% of Con-7d values, respectively, after 7 days of FO.
Changes in HSP25 mRNA expression and protein content.
There were significant main effects for days of FO (P 

0.0001) and for muscle examined (P  0.0001), but there was
no significant interaction effect for days of FO and muscle
examined (P  0.172) for the HSP25 mRNA response. HSP25
mRNA expression relative to -actin was higher than Con at
0.5–2 days of FO in the plantaris and at 0.5 and 1 day of FO
in the soleus (Fig. 1). The highest expression levels were
observed at the earliest time point, with the values being 7.5-
and 5.5-fold higher than Con values after 0.5 days of FO in
the plantaris and soleus, respectively. In general, the HSP25
mRNA expression decreased progressively over time such
that the values for the plantaris at 3 and 7 days and those for
the soleus at 2–7 days of FO were lower than at 0.5 days of
FO. The values tended to be higher in the plantaris than
soleus, but a significant difference was observed only after
2 days of FO.
The higher HSP25 mRNA levels in FO than Con rats were
accompanied by elevated HSP25 protein levels in both the
soleus and plantaris (Figs. 2 and 3). For HSP25 in both the
soluble and insoluble fractions, there were significant main
effects for days of FO (P 
 0.0001 and P 
 0.0001, respec-
tively) and for muscle examined (P  0.0002 and P  0.0248,
respectively) and a significant interaction effect for days of FO
and muscle examined (P  0.0025 and P 
 0.0001, respec-
tively). Compared with Con values, HSP25 levels in the
soluble fraction were unaffected until 2 days of FO (Fig. 2A).
From 2 to 7 days of FO, these values were significantly higher
than Con in both muscles, with the response being significantly
greater in the plantaris than soleus at 3 and 7 days. In addition,
the HSP25 levels at 2–7 days of FO were significantly higher
than at 0.5 and 1 day of FO for both muscles, except for the
plantaris at 2 days of FO. In the insoluble fraction, HSP25
levels in the plantaris were significantly higher than Con at all
time points, whereas in the soleus these values were signifi-
cantly higher than Con only from day 2 to 7 (Fig. 3A). At the
early time points (0.5 and 1 day), the response was significantly
greater in the plantaris than the soleus, whereas the response
was significantly greater in the soleus than plantaris at the later
time points (P  0.05 at day 7). In addition, the HSP25 levels
in the soleus were significantly higher at 2–7 days of FO than
at 0.5 to 1 day of FO.
Changes in HSP25 phosphorylation state. For pHSP25 in
both the soluble and insoluble fractions, there were significant
main effects for days of FO (P 
 0.0001 and P 
 0.0001,
respectively) and for muscle examined (P 
 0.0001 and P 

0.0001, respectively) and a significant interaction effect for
days of FO and muscle examined (P
 0.0001 and P
 0.0001,
respectively). The pHSP25/HSP25 ratio in the soluble fraction
was significantly higher than Con at all time points in the
plantaris and at 2–7 days of FO in the soleus (Fig. 2B). In
addition, the response was significantly greater in the plantaris
than the soleus at all time points. In the insoluble fraction, the
pHSP25/HSP25 ratio was significantly higher than Con in both
muscles at 0.5–2 days and similar to Con thereafter (Fig. 3B).
There was a progressive decrease in the pHSP25/HSP25 ratio
Fig. 1. Average fold changes in heat shock protein (HSP25) mRNA after 0.5,
1, 2, 3, and 7 days of functional overload (FO) in the plantaris and soleus
muscles. The control value is set at 1.0 as indicated by the dashed line. Values
are means  SE. *Significantly different from control, P 
 0.05. †Signifi-
cantly different from 0.5 day, P 
 0.05. Solid horizontal bar indicates a
significant difference between the soleus and plantaris at P 
 0.05.
Fig. 2. Time course of the average relative changes (fold change from control)
in HSP25 protein (A) and phosphorylated HSP25 (pHSP25; B) in the soluble
fraction of the plantaris and soleus muscles after 0.5, 1, 2, 3, and 7 days of FO.
In both graphs, the control value is set at 1.0 as indicated by the dashed line.
Representative Western blots with 3-control (Con) and 3–1 day (1d) FO
plantaris or 3-Con and 3–3 day(3d) FO soleus muscle samples are shown. The
intensity of the phosphorylated bands was first normalized to the intensity of
the corresponding nonphosphorylated bands, and the ratio was normalized to
the control. *Significantly different from Con, P 
 0.05. †Significantly
different from 0.5 day, P
 0.05. #Significantly different from 1 day, P
 0.05.
Solid horizontal bar indicates a significant difference between the soleus and
plantaris at P 
 0.05.
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over time in both muscles, such that the values at 1 day of FO
were significantly lower than at 0.5 days, and the values
thereafter were significantly lower than at both 0.5 and 1 day of
FO. In addition, the response was significantly greater in the
plantaris than the soleus at 0.5 days.
Changes in TNF- protein concentrations. There were sig-
nificant main effects for days of FO (P 
 0.0001) and for
muscle examined (P 
 0.0001) and a significant interaction
effect for days of FO and muscle examined (P  0.0098). At
0 day (Con), the TNF- levels were similar for the plantaris
and soleus (Fig. 4). The TNF- levels in the plantaris at 0.5–2
days of FO were significantly higher than at 0 day, and
thereafter they returned to (3 days) or were lower than (7 days)
Con levels. The levels of TNF- in the soleus were similar to
Con from 0.5 to 2 days, and then after 3 or 7 days of FO,
TNF- levels were significantly lower than the levels observed
at the earlier time points. In addition, the TNF- levels were
significantly higher in the plantaris than the soleus at 0.5–3
days of FO.
TNF- stimulates HSP25 phosphorylation in C2C12 myo-
tubes. Exposure of C2C12 cells to TNF- resulted in a time-
dependent increase in HSP25 phosphorylation via activation of
the MAP kinase pathway (Fig. 5). TNF- increased HSP25
phosphorylation at 15, 30, and 60 min, with maximal phos-
Fig. 3. Time course of the average relative changes (fold change from
control) in HSP25 protein (A) and pHSP25 (B) in the insoluble fraction in
the plantaris and soleus muscles after 0.5, 1, 2, 3, and 7 days of FO. In both
graphs, the control value is set at 1.0 as indicated by the dashed line.
Representative Western blots with 3-Con and 3-1d FO plantaris or 3-Con
and 3-3d FO soleus muscle samples are shown. The intensity of the
phosphorylated bands was first normalized to the intensity of the corre-
sponding nonphosphorylated bands, and the ratio was normalized to the
control. *Significantly different from Con, P 
 0.05. †Significantly differ-
ent from 0.5 day, P 
 0.05. #Significantly different from 1 day, P 
 0.05.
Solid horizontal bar indicates a significant difference between the soleus
and plantaris at P 
 0.05.
Fig. 4. Time course of the average changes in tumor necrosis factor-
(TNF-) protein concentration in the plantaris and soleus muscles after 0
(Con), 0.5, 1, 2, 3, and 7 days of FO. *Significantly different from Con, P 

0.05. ‡Significantly different from 0.5–2 days, P 
 0.05. §Significantly
different from all other time points, P 
 0.05. Solid horizontal bar indicates a
significant difference between the soleus and plantaris at P 
 0.05.
Fig. 5. A: time course of average changes in pHSP25 in C2C12 myotubes
following the addition of 10 ng/ml recombinant murine TNF-. The intensity
of the phosphorylated bands was first normalized to the intensity of the
corresponding nonphosphorylated bands. B: representative Western blots dem-
onstrating that TNF- increased phosphorylation of HSP25 at early time points
before returning to basal levels after 120 min. C: representative Western blots
showing that treatment with SB-203580 (10 or 25 M) blocks phosphorylation
of HSP25 after 30 min of TNF- stimulation without affecting HSP25
expression. In all lanes, cells were treated with 10 ng/ml of TNF-, while lanes
3–6 were pretreated with 1, 10, or 25 M of SB-203580, 30 min before the
addition of TNF-. Values are means SE; n 3 experiments per time point.
OD, optical density. *Significantly different from control (time 0), P 
 0.05.
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phorylation observed at 30 min (Fig. 5A). After 120 min,
pHSP25 had returned to control levels. HSP25 protein levels
were unchanged in response to TNF-. Phosphorylation of
HSP25 by TNF- was blocked in myotubes by treatment with
the p38 MAP kinase inhibitor, SB-203580 (10 M), without
affecting HSP25 expression (Fig. 5B).
DISCUSSION
The present results provide the first evidence that HSP25 is
rapidly phosphorylated and shifts to the insoluble fraction
during the early stages of muscle adaptation to abrupt increases
in loading and activation, particularly in the fast plantaris. This
significant increase in pHSP25 in the insoluble fraction sug-
gests early stabilization of cytoskeletal elements (22) because
this function likely requires large amounts of phosphorylated
HSP25 (32). The higher levels of TNF- in the plantaris
relative to the soleus suggest that TNF- contributes to the
greater pHSP25 response in the soluble fraction in the plantaris
as TNF- increased HSP25 phosphorylation in isolated muscle
cells.
Changes in HSP25 mRNA levels. Following FO, the early
increases in HSP25 mRNA indicate that increases in gene
transcription likely contributed to the later elevations in HSP25
protein observed in both the plantaris and soleus. The increases
in HSP25 mRNA observed after FO are more rapid and of a
greater magnitude than previously reported in a model of
increased muscle activation, i.e., chronic electrical stimulation
(34). In the chronically stimulated (6–10 Hz, 24 h per day)
rabbit tibialis anterior, HSP25 mRNA was unaffected after 8 h,
1 day, or 3 days; began to increase after 7 days; and was
significantly increased above control levels after 14 and 21
days. In contrast, in the present study, the greatest induction of
HSP25 mRNA was observed at the early time points and then
was attenuated with continued FO in both the soleus and
plantaris. Different responses in these two models, however,
were not unexpected, because FO results in an increase in both
activation and loading, whereas low-frequency chronic stimu-
lation increases muscle activation only. FO subjects a muscle
to high loads and results in eventual muscle hypertrophy (2, 3,
25, 45), whereas chronic stimulation increases muscle activa-
tion with little or no additional loading and often results in
muscle atrophy (8, 41). Furthermore, FO is likely associated
with greater muscle damage (5, 50) than low-frequency stim-
ulation. The important role of muscle damage and loading in
increasing HSP25 mRNA is further evidenced by the observa-
tion that a single bout of high-force eccentric contractions
resulted in a 135% increase in HSP25 mRNA 48 h postexercise
in the human biceps brachii (51).
Changes in HSP25 protein and phosphorylation state. These
results demonstrate that the HSP25 response to muscle over-
load is initiated within 0.5 days, particularly in the insoluble
fraction that showed increases in pHSP25 in both muscles and
HSP25 in the plantaris. Rapid changes in the soluble fraction
included a sixfold increase in pHSP25 in the plantaris. It was
important to study HSP25 in both fractions because previous
work has demonstrated translocation of HSP25 to the insoluble
fraction in response to various stressors, including muscle
damage (22) and the accumulation of damaged proteins in
cardiomyocytes (55). Changes in total HSP25 protein in the
soluble fraction are not evident until 2 days after FO. In
humans, 2 days of chronic muscle overload may not be nec-
essary for increases in HSP25 because a single bout of high-
intensity resistance training was associated with increased
HSP25 48 h postexercise (51, 52). Increased levels of HSP25
in overloaded muscles are maintained for at least 7 days in both
the rat soleus and plantaris muscles (15) and during stretch
hypertrophy in the quail anterior latissimus dorsi muscle (49).
Although HSP25 increased in both muscles, the response in
both the soluble and insoluble fractions was muscle specific. In
the soluble fraction, the increase in HSP25 was significantly
greater in the plantaris than the soleus at the later time points,
i.e., after 3 and 7 days of FO. Our laboratory (15) and others
(13, 31) have suggested that the HSP response to a muscle
stressor (i.e., overload, exercise) may be related to the basal
level of HSP expression in the muscle. In the present study, the
greater response in the fast plantaris compared with the slow
soleus may be due in part to the higher basal expression of
HSP25 in muscles composed of predominately slow MHC
compared with muscles with predominately fast MHC profiles
(17, 19, 34). Specifically, our laboratory previously reported
that HSP25 protein levels were 2.5 fold higher in the slow
soleus and adductor longus than the fast plantaris (17). At the
mRNA levels, HSP25 mRNA was approximately threefold
higher in the soleus than the fast (white) region of the vastus
(34). The greater responsiveness in muscles with lower un-
stressed HSP25 content (i.e., plantaris) is supported by a recent
study in humans suggesting that the basal level of HSP expres-
sion (HSP72 and HSP27) in skeletal muscle may contribute to
the “regulation” of HSP expression with exercise training (13).
Furthermore, Morton et al. (31) suggested that the absence of
an increase in HSP27 following nondamaging treadmill run-
ning in humans may been related to its high baseline expres-
sion in the vastus lateralis.
The relative increase in HSP25 in the insoluble fraction was
greater than the response in the soluble fraction at early time
points in the plantaris and at the later time points in the soleus
(cf. Figs. 2A and 3A). The significantly greater increase in
HSP25 in the insoluble fraction in the plantaris compared with
the soleus does not appear to be due to increased transcription
as the mRNA responses are similar between muscles. Thus
further research is needed to determine whether factors such as
increased mRNA stability, translation efficiency, and/or re-
duced protein degradation may have contributed to these find-
ings. However, these early increases in HSP25 in the insoluble
fraction in a fast muscle are consistent with previous work
demonstrating a dramatic shift of HSP25 from the soluble to
the insoluble fraction immediately after a bout of lengthening
contractions in the rat extensor digitorum longus, a predomi-
nantly fast digit extensor (22). Immediately after the muscle
damage induced by lengthening contractions, HSP25 translo-
cated from a diffuse cytosolic location to striations correspond-
ing to the Z disks (22). This observation suggests that the
greater early increase in HSP25 and pHSP25 in the insoluble
fraction in the plantaris relative to the soleus may be related to
more immediate muscle damage in the plantaris and, therefore,
an increased need to limit cytoskeletal damage, remove dam-
aged proteins, and assist in repair. This possibility is consistent
with the observation that fast fibers are more susceptible to
eccentric-induced muscle damage than slow fibers (11, 27).
Interestingly, following nondamaging treadmill running, the
protein content of both HSP70 and HSP60 increased in the
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human vastus lateralis, whereas HSP27 was unchanged, lead-
ing the investigators to suggest that HSP27 is more sensitive to
structural or functional damage than the larger HSPs because
their protocol did not induce muscle damage (31).
Importantly, the translocation of HSP25 to the insoluble
fraction following damaging contractions was associated with
increased phosphorylation (22). The increased phosphorylation
of HSP25 may be important for stabilizing cytoskeletal ele-
ments as shown in other cell types, such as fibroblasts (14, 18,
23, 24). It has been proposed that in unstressed cells, nonphos-
phorylated HSP25 forms large aggregates; however, one of the
earliest responses to stress is HSP25 phosphorylation, which
disrupts the large aggregates allowing HSP25 to interact di-
rectly or indirectly with F-actin and protect it from damage and
actin-severing proteins as well as facilitate subsequent reorga-
nization (32, 57). In muscle cells, the functional significance of
HSP25 phosphorylation is not well understood, and limited
data are available. However, based on our present work and
other work in skeletal (22) and cardiac (7) muscle, increased
HSP25 phosphorylation appears to play a role in the muscle
remodeling processes associated with muscle damage. We
observed substantial early increases in total pHSP25 in the
insoluble fraction in both muscles, and from a functional
standpoint this may contribute to maintaining muscle integrity
as the muscle adapts to the sudden increases in muscle loading
and activation. The subsequent decline in pHSP25 in the
insoluble fraction with continued overload suggests that ongo-
ing muscle remodeling may reduce the need for phosphoryla-
tion-dependent cytoskeletal stabilization.
HSP25 also may protect against the cytotoxic effects asso-
ciated with the proinflammatory cytokine, TNF-. During the
initial stages of FO, an inflammatory response is initiated, and
it is still unclear if this response is physiologically beneficial
(54). Whereas some inflammation ultimately promotes muscle
regeneration and remodeling, excess inflammation is likely
detrimental to muscle remodeling. Macrophages can infiltrate
overloaded skeletal muscles and release proinflammatory cy-
tokines, such as TNF- and interleukin-1 (53). Skeletal mus-
cle TNF-mRNA is increased fourfold in the gastrocnemius of
young rats after 3 days of overload (53). We have shown
significantly higher TNF- levels in the plantaris relative to the
soleus at all time points except 7 days, consistent with previous
reports of higher TNF- expression in fast type II than slow
type I fibers in both humans (43) and rats (42). However,
evidence suggests that the cytotoxic effects of TNF- may be
reduced by elevated levels of HSP25. Specifically, overexpres-
sion of HSP25 was associated with significant reductions in
TNF--induced oxidative damage in L929 fibroblasts (40, 44).
In addition, protection against the cytotoxic effects of TNF-
were reduced in a dose-dependent fashion by increasing
HSP25 expression in L929 cells (30). Interestingly, L929 cells,
which are highly sensitive to TNF--induced damage, do not
seem to express HSP25 (26).
Although the protective actions of HSP25 against TNF--
induced damage may not involve increased phosphorylation
(44), TNF- is associated with increased pHSP25 in muscle
cells (present in vitro results) and other cell types (9, 39). This
increase in pHSP25, however, may serve to stabilize cytoskel-
etal elements and maintain muscle integrity because these
functions appear to be phosphorylation dependent (32, 57). The
close temporal relationship between elevated TNF- and
pHSP25 in the plantaris relative to the soleus suggests that
TNF- contributes to the significantly greater pHSP25 re-
sponse in the plantaris (soluble fraction).
HSP25 is one member of a large family of HSPs that may
contribute to the adaptation of skeletal muscle to overload
stress. We recognize that the physiological functions of HSP25
may be impacted by other HSPs, in particular, the other small
HSPs, -crystallin and HSP20 (57). Furthermore, several
studies to date have shown significant increases in HSP70
(HSP72) after 14–28 days in the overloaded rat plantaris
(36–38) and increases in HSP70 within 48 h of a bout of
eccentric exercise in humans (51, 52).
In summary and conclusion, we have presented novel results
demonstrating the earliest reported changes in HSP25 localiza-
tion and phosphorylation and in the proinflammatory cytokine,
TNF-, associated with increases in muscle loading and acti-
vation. Importantly, the differences in the responses between
the predominantly slow soleus and the predominantly fast
plantaris highlight the variability in the stress experienced by
each muscle during adaptation to FO. One such difference was
the elevation in TNF-, which may be a mechanism contrib-
uting to the greater pHSP25 response in the soluble fraction in
the plantaris compared with the soleus after 0.5, 1, 2, and 3
days of FO. Strong support for this possibility is the close
temporal association with the highest levels of TNF- and
pHSP25 in the plantaris and the phosphorylation of HSP25 by
TNF- in isolated skeletal muscle cells.
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